Freudenberg Medical acquires hypotube manufacturing business of Merit Medical Systems
Freudenberg Medical has acquired the manufacturing equipment and associated assets used by Merit Medical Systems in its hypotube manufacturing business, for an undisclosed price. The ... Read More
RELIEF-DPN-1 clinical trial : Lexicon begins patient dosing with LX9211
RELIEF-DPN-1 clinical trial : Lexicon Pharmaceuticals has started patient dosing in a phase 2 trial of LX9211 for the treatment of diabetic peripheral neuropathic pain. ... Read More
FDA accepts Ascendis Pharma’s TransCon hGH BLA for pediatric GHD
Ascendis Pharma, a Danish biopharma company, said that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for TransCon hGH ... Read More
Nestlé to fully own Aimmune Therapeutics through $2bn deal
Nestlé will take full ownership of Aimmune Therapeutics, the developer of FDA approved peanut allergy drug Palforzia, by acquiring the remaining stake of 74.4% in ... Read More
Ionis Pharmaceuticals to take full ownership of Akcea Therapeutics
Ionis Pharmaceuticals is set to take full ownership of Akcea Therapeutics by acquiring the remaining stake of around 24% in the latter for about $500 ... Read More
Rocket Pharmaceuticals gets FDA fast track status for RP-L401 in infantile malignant osteopetrosis
Rocket Pharmaceuticals has secured fast track designation for RP-L401 gene therapy candidate from the US Food and Drug Administration (FDA) for the treatment of infantile ... Read More
Clene Nanomedicine raises $42.5m for developing nanocatalysts for neurodegenerative diseases
Clene Nanomedicine, which is engaged in developing nanocatalysts for the treatment of bioenergetic failure associated with neurodegenerative diseases, has raised $42.5 million in a Series ... Read More
Kohlberg, Mubadala to acquire majority stake in PCI Pharma Services
Kohlberg & Company and Mubadala Investment have agreed to acquire a majority stake in drug development solutions provider PCI Pharma Services, a portfolio company of ... Read More
Takeda to divest consumer healthcare business to Blackstone for $2.3bn
Japanese pharma giant Takeda Pharmaceutical has agreed to sell its consumer healthcare business to Oscar A-Co KK, a company controlled by funds managed by The ... Read More
SAB Biotherapeutics begins phase 1b Covid-19 trial of SAB-185
SAB Biotherapeutics, a US biopharma company, said that the first patient in a phase 1b clinical trial of its investigational Covid-19 therapeutic SAB-185 has been ... Read More